知镜 Cognispect · 医学文献与研究工作台

Pan-Cancer Landscape of Interferon-Induced Protein 35 and Its Tumor-Promoting Role in Breast Cancer.

Mu Y, Zhang T, He L, Li J, Liu P.
The Journal of surgical research · 2026-08-14 · PMID 42600432

文献摘要

Introduction Interferon-induced protein 35 (IFI35) is a critical regulator of virus-induced immune-inflammatory responses; however, its systematic role in cancer, particularly in breast cancer (BRCA), remains unclear. This study aimed to elucidate the pan-cancer expression profile and prognostic value of IFI35 and to elucidate its functional and clinical significance in BRCA. Methods Public databases, including The Cancer Genome Atlas and Clinical Proteomic Tumor Analysis Consortium, were used to analyze IFI35 expression, prognostic value, and its association with the tumor microenvironment. Protein expression in BRCA was validated on tissue microarrays using immunohistochemistry. The function of IFI35 in proliferation, migration, invasion, and apoptosis of BRCA cells was explored through in vitro experiments and nude mouse xenograft models. Results IFI35 expression was significantly upregulated at both messenger RNA and protein levels in multiple cancers, most prominently in BRCA, as well as in glioblastoma multiforme, head and neck squamous cell carcinoma, kidney renal clear cell carcinoma, and liver hepatocellular carcinoma (P 1, P Conclusions Our study revealed that IFI35 contributes to the progression of BRCA and is a potential therapeutic target for BRCA.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。